The fate of transplanted xenogeneic bone marrow‐derived stem cells in rat intervertebral discs
暂无分享,去创建一个
[1] I. Rasmusson. Immune modulation by mesenchymal stem cells. , 2006, Experimental cell research.
[2] Hanns-Ulrich Marschall,et al. Mesenchymal Stem Cells for Treatment of Therapy-Resistant Graft-versus-Host Disease , 2006, Transplantation.
[3] A. Freemont,et al. Intervertebral Disc Cell–Mediated Mesenchymal Stem Cell Differentiation , 2006, Stem cells.
[4] Joji Mochida,et al. Differentiation of Mesenchymal Stem Cells Transplanted to a Rabbit Degenerative Disc Model: Potential and Limitations for Stem Cell Therapy in Disc Regeneration , 2005, Spine.
[5] J. Lotz,et al. The potential role of mesenchymal stem cell therapy for intervertebral disc degeneration: a critical overview. , 2005, Neurosurgical focus.
[6] J Ratajczak,et al. Bone marrow as a home of heterogenous populations of nonhematopoietic stem cells , 2005, Leukemia.
[7] W. Olszewski. Innate immunity processes in organ allografting--their contribution to acute and chronic rejection. , 2005, Annals of transplantation.
[8] Anja Winter,et al. Induction of Intervertebral Disc–Like Cells From Adult Mesenchymal Stem Cells , 2005, Stem cells.
[9] I. Yaniv,et al. Induction of tolerance using Fas ligand: a double-edged immunomodulator. , 2005, Blood.
[10] Xiong Guo,et al. Bone Mesenchymal Stem Cells Transplanted into Rabbit Intervertebral Discs Can Increase Proteoglycans , 2005, Clinical orthopaedics and related research.
[11] Yongjun Wang,et al. Gene expression profile of degenerated cervical intervertebral disc tissues in rats. , 2004, Chinese journal of traumatology = Zhonghua chuang shang za zhi.
[12] P. Roughley. Biology of Intervertebral Disc Aging and Degeneration: Involvement of the Extracellular Matrix , 2004, Spine.
[13] M. Kurosaka,et al. Fas-Ligand Expression on Nucleus Pulposus Begins in Developing Embryo , 2004, Spine.
[14] C. Civin,et al. Fas Ligand as a Tool for Immunosuppression and Generation of Immune Tolerance , 2004, Stem cells.
[15] Yong-Guang Yang. Application of xenogeneic stem cells for induction of transplantation tolerance: present state and future directions , 2004, Springer Seminars in Immunopathology.
[16] M. Usuda,et al. MACROPHAGE DEPLETION PREVENTS ANTI-GRAFT ANTIBODY PRODUCTION AND RESULTS IN LONG TERM SURVIVAL IN XENOTRANSPLANTATION , 2004, Transplantation proceedings.
[17] Jeffrey C Lotz,et al. Biological response of the intervertebral disc to dynamic loading. , 2004, Journal of biomechanics.
[18] George M. Wahba,et al. Intervertebral Disc Cell Therapy for Regeneration: Mesenchymal Stem Cell Implantation in Rat Intervertebral Discs , 2004, Annals of Biomedical Engineering.
[19] Chulhee Choi,et al. Fas ligand/Fas system in the brain: regulator of immune and apoptotic responses , 2004, Brain Research Reviews.
[20] D. Bonnet. Biology of human bone marrow stem cells , 2003, Clinical and Experimental Medicine.
[21] Safdar N. Khan,et al. The molecular basis of intervertebral disk degeneration. , 2003, The Orthopedic clinics of North America.
[22] M. Lübbert,et al. CD34− Hematopoietic Stem Cells: Current Concepts and Controversies , 2003, Stem cells.
[23] S. Roberts,et al. Disc morphology in health and disease. , 2002, Biochemical Society transactions.
[24] M. Kurosaka,et al. Fas Ligand Exists on Intervertebral Disc Cells: A Potential Molecular Mechanism for Immune Privilege of the Disc , 2002, Spine.
[25] M. Bhatia,et al. Characterization of retroviral gene transfer into highly purified human CD34(-) cells with primitive hematopoietic capacity. , 2002, Molecular therapy : the journal of the American Society of Gene Therapy.
[26] A. Freemont,et al. Current understanding of cellular and molecular events in intervertebral disc degeneration: implications for therapy , 2002, The Journal of pathology.
[27] R. Colvin,et al. Tolerance, Mixed Chimerism, and Chronic Transplant Arteriopathy1 2 , 2001, The Journal of Immunology.
[28] Jong-Beom Park,et al. Expression of Fas Ligand and Apoptosis of Disc Cells in Herniated Lumbar Disc Tissue , 2001, Spine.
[29] D. Krause,et al. Hematopoietic Stem Cells Can Be CD34+ or CD34- , 2001, Leukemia & lymphoma.
[30] R. Fessler,et al. Molecular Biology of Degenerative Disc Disease , 2000, Neurosurgery.
[31] F. Cammisa,et al. Current concepts in intervertebral disc restoration. , 2000, The Orthopedic clinics of North America.
[32] J. Nolta,et al. CD34: To select or not to select? That is the question , 2000, Leukemia.
[33] S. Nagata,et al. Fas ligand-induced apoptosis. , 1999, Annual review of genetics.
[34] M. Ogawa,et al. Engraftment and Multilineage Expression of Human Bone Marrow CD34− Cells In Vivo a , 1999, Annals of the New York Academy of Sciences.
[35] M. Ogawa,et al. Human bone marrow CD34- cells engraft in vivo and undergo multilineage expression that includes giving rise to CD34+ cells. , 1998, Experimental hematology.
[36] K. Okumura,et al. CD95 ligand in graft rejection , 1996, Nature.
[37] D. Green,et al. Fas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege , 1995, Science.
[38] K. Ando,et al. Regenerative effects of transplanting mesenchymal stem cells embedded in atelocollagen to the degenerated intervertebral disc. , 2006, Biomaterials.
[39] J. Mosca,et al. T cell responses to allogeneic human mesenchymal stem cells: immunogenicity, tolerance, and suppression. , 2005, Journal of biomedical science.
[40] H. Brisby,et al. Cell therapy for disc degeneration--potentials and pitfalls. , 2004, The Orthopedic clinics of North America.
[41] Kevin McIntosh,et al. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. , 2002, Experimental hematology.
[42] J. Dick,et al. Distinct classes of human stem cells that differ in proliferative and self-renewal potential , 2001, Nature Immunology.
[43] M. Fackler,et al. CD34: structure, biology, and clinical utility. , 1996, Blood.